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Objective: To assess if the risk of first-time
salpingectomy was affected by prior hysterectomy with
retained fallopian tubes and by prior sterilisation.
Design: A historical cohort study.
Setting: Denmark.
Participants: 170 000 randomly selected women
born 1947–1963 (10 000/year) were followed from
1977 until the end of 2010.
Main outcome measures: Effect of hysterectomy
with retained fallopian tubes or sterilisation on the risk
of salpingectomy. Both were modelled in a Cox
proportional hazards model as time-dependent
covariates, analysing time to first salpingectomy. End
of follow-up period was 31 December 2010.
Results: Of 9591 hysterectomies, 6456 (67.3%) had
both fallopian tubes retained. HRs for salpingectomy
after hysterectomy with retained fallopian tubes and
sterilisation were 2.13 (95% 1.88 to 2.42) and 2.42
(2.21 to 2.64), as compared with those for
non-hysterectomised and non-sterilised women.
Conclusions: Women undergoing hysterectomy with
retained fallopian tubes or sterilisation have at least a
doubled risk of subsequent salpingectomy. Removal of
the fallopian tubes at hysterectomy should therefore be
recommended.
INTRODUCTION
Hysterectomy is the most frequently per-
formed gynaecological surgical intervention
among women of reproductive age. In
Denmark, there are annually approximately
5000 hysterectomies of benign indication. In
2010, the simultaneous removal of the ovaries
and the fallopian tubes was performed in 12%
of the hysterectomies.1 After hysterectomy, the
blood supply of the ovaries is secured via the
infundibulopelvic ligament, and the hormone
proﬁle is left unaltered by salpingectomy.2–4
No long-term negative effects of salpingectomy
at hysterectomy have been reported. The
blind-ended remnants of the fallopian tubes
may instead give rise to complications such as
hydrosalpinx, infection, benign tumours, tube
prolapse/torsion, and perhaps induction of
ovarian cancer,4–7 the most frequent being
hydrosalpinx (35.5%).8 9 Hysterectomised
women have a 7.8% lifetime risk of subsequent
surgery of adnexae.10
Malignant tumours of the fallopian tube are
rare. A reconsideration of the ovarian cancer
aetiology is ongoing. One hypothesis suggests
that serous epithelial carcinomas originating
from the distal end of the fallopian tube may
be the origin of some ovarian cancers and/or
primary peritoneal cancers.11–17
Hydrosalpinx and other tubal pathology
with succeeding salpingectomy can also
occur after sterilisation, which is the most fre-
quently applied contraceptive method world-
wide. United Nations statistics estimate an
annual 200 million sterilised women of
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reproductive age.18 Surgical techniques of sterilisation
vary worldwide.19 However, laparoscopic coagulation of
the isthmic portion is generally preferred. In Denmark,
ligation with clips is the most frequently used tech-
nique20 whereby the ﬁmbriated end of the fallopian
tube is left unaffected. This implies a risk of subsequent
pathology in the tubes.
Our hypothesis is that there is a potential risk for a
second major surgery after both hysterectomy and steril-
isation with retained fallopian tubes.
The aim of our study was to assess the effect of hyster-
ectomy with retained fallopian tubes, and sterilisation
on the risk of ﬁrst-time salpingectomy in order to
provide an improved empirical basis for deciding
whether the fallopian tubes should be removed routinely
at a hysterectomy (on benign indication).
METHODS
Study population
From the Danish Civil Registration System, we randomly
selected 10 000 women born each year from 1947 to
1963 who were alive on January 1 of the year in which
they turned 40 years. Thereby, the included women were
between 15 and 30 years of age at the start of the obser-
vation period (1 January 1977), and had a follow-up to
at least the age of 47 years (end of follow-up was 31
December 2010). Occurrences of surgical codes for hys-
terectomy, salpingectomy, oophorectomy or combina-
tions of these were retrieved from the Danish National
Patient Registry (established in 1977)21 for each of these
170 000 women. Procedural codes are given in table 1.
Statistical analyses
The cause-speciﬁc hazard of time to the ﬁrst salpingec-
tomy was modelled by a Cox proportional hazards
approach, including time-dependent hysterectomy and
sterilisation status and birth cohort as categorical covari-
ates (1947–51, 1952–56 and 1957–63).22 HRs were pre-
sented with 95% CIs.
The various hysterectomy types and techniques are
included in the same model since they all, despite their
heterogeneity, contain the possibility of retaining the fal-
lopian tubes, and thereby potentially enhance the risk of
tubal pathology.
To illustrate the time aspect of potential salpingectomy
after hysterectomy, the cumulative incidence curves for
salpingectomy were estimated for the three included
birth cohorts.
RESULTS
We identiﬁed 9591 hysterectomies during the study
period of which 6456 (67.3%) had retained fallopian
tubes. Sterilisation was performed in 9829 women, and
7167 had a salpingectomy (table 1).
The cohort-adjusted HRs for salpingectomy after hys-
terectomy with retained fallopian tubes and after steril-
isation were 2.13 (95% CI 1.88 to 2.42) and 2.42 (2.21
to 2.64), as compared with those for non-
hysterectomised and non-sterilised women (table 2).
Hysterectomy as well as sterilisation thus increased the
risk for a subsequent salpingectomy.
Figure 1 shows the cumulative incidence curve by
cohort for salpingectomy after hysterectomy. The cumu-
lative incidence was highest for the youngest cohort.
Five and 10 years after hysterectomy, the numbers of
ﬁrst-time salpingectomy, death or end of follow-up are
presented in table 3. There were increasing numbers of
salpingectomies after hysterectomy with succeeding
birth cohorts, with the youngest women having the
highest proportion of salpingectomies after hysterec-
tomy. In absolute terms, after 10 years, 85/2172=3.9%
women were salpingectomised. For all three cohorts,
Table 1 Number of included surgical procedures in the Danish National Patient Registry from 1 January 1977 to 31











Women alive on 1 January
of the first year
170 000 170 000 168 725 163 693
Unilateral
salpingo-oophorectomy
60300 KLAF00/01 537 716 946 250
Bilateral
salpingo-oophorectomy
60320 KLAF10/11 58 246 1213 632
Unilateral salpingectomy 60460 KLBE00/01 831 905 475 68
Bilateral salpingectomy 60480 KLBE00/01 138 152 – –
Supravaginal hysterectomy 61000 KLCC10/11/20 19 430 944 111
Total abdominal
hysterectomy
61020 KLCD00/01/04/11 855 2179 2835 911
Total vaginal hysterectomy 61040 KLCD10 11 68 667 311
Radical hysterectomy 61100 KLCD30/31/40 33 108 74 35
Sterilisation 608.00–40 KLGA00–98 2675 4424 2649 81
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about two-thirds of salpingectomies were performed
within 5 years after hysterectomy.
DISCUSSION
Principal findings
Women undergoing hysterectomy with retained fallo-
pian tubes or sterilisation had at least a doubled risk of
succeeding salpingectomy in our study as compared with
women without these surgeries.
To the best of our knowledge, no previous study has inves-
tigated this on a national level. Small cohort studies (n=38,
82 and 337, respectively) have described that retained fallo-
pian tubes may give rise to tubal pathology.8–10
The cumulative incidence of salpingectomy after hys-
terectomy with retained fallopian tubes increased in the
latest cohort. This can be explained by the development
and introduction of ultrasound examinations which
increase the chance of detecting pathological tubes. The
clinical signiﬁcance of leaving ‘orphan’ ovaries is
unknown. Salpingectomy may cause early cystic degener-
ation of the remaining ovaries,9 which is of unknown sig-
niﬁcance. The hormone production is not altered after
salpingectomy.2–4 We believe that a salpingectomy,
carefully and properly carried out at the same time as a
hysterectomy, is not associated with any risk of disturbed
ovarian function. To leave the ovaries undisturbed, sal-
pingectomy should be performed with ligation/dia-
thermy of the three major vessels from the ovarian
pedicle to the fallopian tube, as far away from the ovary
as possible.
Age at menopause could be another issue, but we
found no study on the inﬂuence of removal of the fallo-
pian tube concomitantly with hysterectomy on age at
menopause. The time aspect of an extended operation
owing to concomitant salpingectomy is negligible. We
could not extract any data indicating disadvantages asso-
ciated with removal of the fallopian tubes at the same
time as a hysterectomy. Salpingectomy as a sterilisation
procedure, however, excludes the possibility of later
refertilisation by surgical reanastomosis (although the in
vitro fertilisation would nowadays be the standard treat-
ment instead of reanastomosis). The decision of conven-
tional sterilisation or salpingectomy should, therefore,
be discussed individually with each woman. The infor-
mation to these women should emphasise the risk of
regret, complications to surgery and the potential risk of
health hazards with retained fallopian tubes.
The Danish National Patient Registry is a valuable
source of data. It records 99.4% of all discharges from
hospitals in Denmark, and the surgical procedures for
hysterectomy have been validated and show a high
quality of the data with positive predictive values of 90–
99%.23 24
Limitations
For women entering the study at an age close to
30 years, there is potential missing information on rele-
vant procedures at a younger age. The need for hysterec-
tomy before the age of 30 is, however, low. No
information on emigration was included in the analysis.
The current study has not been focusing on the devel-
opment of gynaecological cancer after hysterectomy or
sterilisation. The follow-up was to a maximum age of 63,
and therefore we had insufﬁcient power for assessing
the risk of tubal or ovarian cancer.
Risk-reducing surgical intervention
Prophylactic removal of the fallopian tubes during hys-
terectomy or even sterilisation would rule out any subse-
quent tubal pathology and succeeding salpingectomy.
This is further tempting with the hypothesis that pelvic
or ovarian serous carcinomas may originate from the fal-
lopian tubes.14 Recommendations of prophylactic salpin-
gectomy during hysterectomy or tubal ligation have
been published.25–27 These recommendations are in line
with our ﬁndings.
Other ways of risk-reducing surgical interventions have
been discussed in the literature
1. Bilateral salpingectomy with ovarian retention as a poten-
tial temporary, short-term intermediate step towards bilat-
eral oophorectomy in younger BRCA1/2 mutation
Table 2 Estimated effect (HRs) of hysterectomy with
retained fallopian tubes, sterilisation and birth cohorts on




Cohort 1947–1951 1 Reference 0.0004
Cohort 1952–1956 1.02 0.96 to 1.09




Hysterectomy 2.13 1.88 to 2.42 <0.001
Sterilisation 2.42 2.21 to 2.64 <0.001
Figure 1 Cumulative incidence curves for first-time
salpingectomy after hysterectomy by cohort, based on
N=6456 hysterectomies.
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carriers not yet prepared to undergo premature meno-
pause after risk-reducing salpingo-oophorectomy.28
2. Removing the fallopian tubes at the time of a caesar-
ean section in women during their last delivery,29
though these latter risk-reducing surgical interven-
tions lack research data before an evidence-based
decision can be made.
CONCLUSIONS
We found that women undergoing hysterectomy or ster-
ilisation with retained fallopian tubes had at least a
doubled risk of succeeding salpingectomy. Therefore,
removal of the fallopian tubes at a hysterectomy should
be recommended. Salpingectomy as a sterilisation pro-
cedure should be discussed thoroughly with the patient
before deciding on the approach to be adopted.
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